I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 24% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 24% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 31% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 766.51 | 245 / 245 | 100% | 15.99 | 502 / 502 |
| esophagus | 100% | 790.53 | 1443 / 1445 | 100% | 20.88 | 183 / 183 |
| breast | 100% | 726.12 | 459 / 459 | 100% | 17.78 | 1116 / 1118 |
| ovary | 100% | 734.07 | 180 / 180 | 100% | 10.65 | 429 / 430 |
| stomach | 100% | 606.94 | 358 / 359 | 100% | 18.80 | 286 / 286 |
| intestine | 100% | 741.69 | 966 / 966 | 100% | 20.39 | 525 / 527 |
| thymus | 100% | 1045.52 | 653 / 653 | 100% | 20.93 | 602 / 605 |
| pancreas | 100% | 905.78 | 328 / 328 | 99% | 11.16 | 177 / 178 |
| bladder | 100% | 716.90 | 21 / 21 | 99% | 14.80 | 500 / 504 |
| lung | 99% | 584.44 | 572 / 578 | 100% | 15.80 | 1153 / 1155 |
| kidney | 100% | 858.20 | 89 / 89 | 99% | 13.26 | 889 / 901 |
| uterus | 100% | 740.03 | 170 / 170 | 98% | 15.73 | 452 / 459 |
| brain | 99% | 885.85 | 2612 / 2642 | 99% | 8.43 | 701 / 705 |
| liver | 100% | 927.13 | 226 / 226 | 98% | 9.18 | 396 / 406 |
| adrenal gland | 100% | 727.32 | 258 / 258 | 96% | 8.19 | 221 / 230 |
| skin | 100% | 1164.14 | 1807 / 1809 | 91% | 11.54 | 430 / 472 |
| spleen | 100% | 726.23 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 15.05 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.84 | 1 / 1 |
| adipose | 100% | 661.82 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 537.70 | 800 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 455.56 | 1321 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 12.88 | 28 / 29 |
| heart | 94% | 386.29 | 809 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 70% | 6.59 | 56 / 80 |
| peripheral blood | 44% | 450.79 | 412 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0032259 | Biological process | methylation |
| GO_0035498 | Biological process | carnosine metabolic process |
| GO_0006548 | Biological process | L-histidine catabolic process |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0008757 | Molecular function | S-adenosylmethionine-dependent methyltransferase activity |
| GO_0030735 | Molecular function | carnosine N-methyltransferase activity |
| Gene name | CARNMT1 |
| Protein name | Carnosine N-methyltransferase (EC 2.1.1.22) Carnosine N-methyltransferase 1 |
| Synonyms | C9orf41 |
| Description | FUNCTION: N-methyltransferase that catalyzes the formation of anserine (beta-alanyl-N(Pi)-methyl-L-histidine) from carnosine. Anserine, a methylated derivative of carnosine (beta-alanyl-L-histidine), is an abundant constituent of vertebrate skeletal muscles. Also methylates other L-histidine-containing di- and tripeptides such as Gly-Gly-His, Gly-His and homocarnosine (GABA-His). . |
| Accessions | Q5T8U9 ENST00000376834.8 ENST00000451153.1 ENST00000376830.3 Q5T8V1 Q8N4J0 |
